4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
6.66
-0.03 (-0.45%)
At close: Sep 17, 2025, 4:00 PM EDT
6.88
+0.22 (3.30%)
Pre-market: Sep 18, 2025, 5:47 AM EDT
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $311.04 million as of September 18, 2025. Its market cap has decreased by -60.13% in one year.
Market Cap
311.04M
Enterprise Value
-82.92M
1-Year Change
-60.13%
Ranking
Category
Stock Price
$6.66
Market Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has decreased from $580.38M to $311.04M, a decrease of -46.41%. That is a compound annual growth rate of -12.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 311.04M | 20.80% |
| Dec 31, 2024 | 257.49M | -70.27% |
| Dec 29, 2023 | 866.19M | 20.40% |
| Dec 30, 2022 | 719.43M | 2.03% |
| Dec 31, 2021 | 705.13M | -35.79% |
| Dec 31, 2020 | 1.10B | 89.22% |
| Dec 11, 2020 | 580.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.40B |
| Johnson & Johnson | 426.76B |
| AbbVie | 390.07B |
| UnitedHealth Group | 309.39B |
| Novo Nordisk | 260.64B |
| AstraZeneca | 241.43B |
| Novartis AG | 237.64B |
| Abbott Laboratories | 233.52B |